Press releases - 5

Domain Therapeutics’ innovative business model gains validation through Prexton Therapeutics acqui...

Domain Therapeutics grants Bristol-Myers Squibb non-exclusive license for G protein-coupled receptor...

Domain Therapeutics and 5 SATTs announce an innovative commercial and scientific partnership to acce...

Domain Therapeutics launches dedicated bioSensAll™ website

Pfizer Inc. and Domain Therapeutics enter into a collaboration agreement on bioSensAll™

Domain Therapeutics and Merck enter into a license and collaboration agreement for development of ad...

Domain Therapeutics grants Alkermes a non-exclusive license for its G Protein-Coupled Receptor BioSe...

Domain Therapeutics and Medicxi launch Mavalon Therapeutics, aimed at halting the progression of Par...

Domain Therapeutics, Université de Montréal, IRICoR and McGill University extend licensing and par...

PeptiMimesis: New biotech startup developing next generation therapeutic peptides in immuno-oncology...